Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis

Blood. 2014 May 1;123(18):2899-900. doi: 10.1182/blood-2014-02-556514.
No abstract available

Publication types

  • Letter

MeSH terms

  • Amyloidosis / complications*
  • Amyloidosis / metabolism*
  • Factor X / administration & dosage
  • Factor X / therapeutic use*
  • Factor X Deficiency / complications*
  • Factor X Deficiency / drug therapy*
  • Humans
  • Immunoglobulin Light Chains / metabolism*
  • Treatment Outcome

Substances

  • Immunoglobulin Light Chains
  • Factor X